Gary M. Owens, MD, and Lawrence Eichenfield, MD, discuss how an atopic dermatitis therapy demonstrates significant clinical efficacy through targeted JAK inhibition, providing sustained symptom relief, reduced healthcare utilization, and decreased steroid dependency across diverse patient populations as evidenced by 18-month retrospective claims analysis.
EP. 1: Key Background Information on Atopic Dermatitis
March 17th 2025Panelists discuss how atopic dermatitis, a chronic inflammatory skin condition characterized by intense itching and recurring eczematous lesions, affects millions worldwide, with complex genetic and environmental factors influencing its development, progression, and treatment response.
Watch